On August 27, 2025, the U.S. Food and Drug Administration (FDA) granted approval for updated COVID‑19 vaccines targeting the LP.8.1 sublineage of the virus. These new formulations—from Pfizer‑BioNTech (Comirnaty), Moderna (Spikevax and…
Your Path to a Thriving Life
On August 27, 2025, the U.S. Food and Drug Administration (FDA) granted approval for updated COVID‑19 vaccines targeting the LP.8.1 sublineage of the virus. These new formulations—from Pfizer‑BioNTech (Comirnaty), Moderna (Spikevax and…